On December 6, 2022, Missouri Baptist Medical Center performed its 1,000th transcatheter aortic valve replacement (TAVR).
“We are proud to reach this milestone,” says Michael Mauney, MD, cardiothoracic surgeon on staff at Missouri Baptist. “MoBap was among the first medical centers in the nation to adopt this procedure following FDA approval in Fall 2011.”
TAVR is a minimally invasive procedure for replacing a stenotic (tight) aortic valve in which the aortic valve narrows, reducing blood flow from the heart to the aorta. This procedure can also replace failed artificial aortic and mitral valves. TAVR is a treatment option to be considered for those with severe aortic stenosis, including many with worn-out surgical valves.